This information is disseminated under the sponsorship of the U.S. Department of Transportation in the interest of information exchange. The United States Government assumes no Liability for the contents or use thereof.

Olanzapine
Description ZYPREXA® is indicated for the treatment of schizophrenia. 
Therapeutic Low 0.0090
Therapeutic High 0.0230
Units ug/mL 
Specimen P 
Half Life Low 21.00
Half Life High 54.00
VOD Low 10.00
VOD High 20.00
Toxic Level 0.000
Lethal Level 1.200
Plasma to Whole Blood ratio 0.00
Warnings Warnings - Because olanzapine has the potential to impair judgment, thinking, or motor skills, patients should be cautioned about operating hazardous machinery, including automobiles, until they are reasonably certain that olanzapine therapy does not affect them adversely.